Mizuho Securities USA LLC Has $1.58 Million Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Mizuho Securities USA LLC boosted its position in Molina Healthcare, Inc. (NYSE:MOH) by 42.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,421 shares of the company’s stock after buying an additional 1,621 shares during the quarter. Mizuho Securities USA LLC’s holdings in Molina Healthcare were worth $1,578,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. Waldron Private Wealth LLC grew its position in shares of Molina Healthcare by 4.7% in the fourth quarter. Waldron Private Wealth LLC now owns 729 shares of the company’s stock valued at $212,000 after purchasing an additional 33 shares during the last quarter. Bank of Hawaii grew its holdings in Molina Healthcare by 4.6% in the 3rd quarter. Bank of Hawaii now owns 1,224 shares of the company’s stock valued at $422,000 after buying an additional 54 shares during the last quarter. HighTower Advisors LLC increased its position in Molina Healthcare by 2.1% in the 3rd quarter. HighTower Advisors LLC now owns 2,627 shares of the company’s stock worth $906,000 after buying an additional 55 shares during the period. Lindbrook Capital LLC lifted its holdings in shares of Molina Healthcare by 38.5% during the fourth quarter. Lindbrook Capital LLC now owns 205 shares of the company’s stock worth $60,000 after buying an additional 57 shares during the last quarter. Finally, Brooklyn Investment Group boosted its position in shares of Molina Healthcare by 20.1% in the fourth quarter. Brooklyn Investment Group now owns 400 shares of the company’s stock valued at $116,000 after acquiring an additional 67 shares during the period. Institutional investors own 98.50% of the company’s stock.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.10% of the stock is currently owned by corporate insiders.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $310.55 on Wednesday. The firm has a market capitalization of $16.99 billion, a P/E ratio of 15.20, a P/E/G ratio of 1.06 and a beta of 0.56. The stock has a fifty day moving average price of $300.36 and a two-hundred day moving average price of $309.09. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $423.92. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Mizuho cut their target price on shares of Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Stephens reiterated an “equal weight” rating and issued a $345.00 target price on shares of Molina Healthcare in a research note on Thursday, February 6th. UBS Group lowered their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company raised Molina Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $355.69.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.